A clinical trial of obinutuzumab and Venetoclax in CLL newly diagnosed fit patients
Latest Information Update: 19 Sep 2024
At a glance
- Drugs Obinutuzumab (Primary) ; Venetoclax (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 19 Sep 2024 New trial record